Abstract
CD38 was initially identified more than two decades back when murine monoclonal antibodies (mAbs) were being employed to define newer surface molecules expressed by the lymphocytes during various developmental stages. One such mAb (T10) was successfully employed in the analysis of distribution [1] and biochemical characterization of CD38 antigen [2]. The conclusions derived from the biochemical analysis of the molecule were independently confirmed by cloning of a cDNA for human CD38 in 1990 [3]. On the basis of its expression and allocation among immune cells, CD38 was referred to as an “activation marker” and till recently was used for phenotyping the differentiation state of lymphocytes and classifying leukemias.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Refrences
Reinherz EL, Kung PC, Goldstein G, Levey RH and Schlossman SF. 1980. Discrete stages of intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T lineage. Proc. Natl. Acad. Sci. USA 11: 1588–1592.
Terhorst C, van Agthoven A, Le Clair K, Snow P, Reinherz EL and Schlossman SF. 1981. Biochemical studies of the human thymocyte cell-surface antigens T6, T9 and T10. Cell 23:771–778.
Jackson D and Bell JI. 1990. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with unusual discontinuous pattern of expression during lymphocyte differentiation. J. Immunol. 144: 2811–2817.
States DJ, Walseth TF and Lee HC. 1992. Similarities in amino acid sequences of Aplysia ADP ribosyl cyclase and human lymphocyte antigen CD38. Trends Biochem. Sci. 17: 495.
Howard M, Grimaldi JC, Bazan JF, Lund FE, Santos-Argumedo L, Parkhouse RM, Walseth TF and Lee HC. 1993. Formation and hydrolysis of cyclic ADP ribose by lymphocyte antigen CD38. Science 262: 1056–1059.
Zocchi E, Franco L, Guida L, Benatti U, Bargellesi A, Malavasi F, Lee HC and De Flora F. A single protein immunologically identified as CD38 displays NAD+-glycohydrolase, ADP ribosyl cyclase and cyclic ADP-ribose hydrolase activities in the auter surface of human erythrocytes. Biochem. Biophys. Res. Commun. 196: 1459–1465.
Ramaschi G, Torti M, Tolnai Festetics E, Sinigaglia F, Malavasi F and Balduini C. 1996. Expression of cyclic ADP-ribose-synthetizing CD38 molecule of human platelet membrane. Blood 87: 2308–2313.
Dianzani U, Funaro A, DiFranco D, Garbarino G, Bragardo M, Redoglia V, Buonfiglio D, DeMonte LB, Piled A and Malavasi F. 1994. Interaction between endothelium and CD4+TD45RA+ lymphocytes. J. Immunol. 22: 952–959.
Ausiello CM, Urbani F, LaSala A, Funaro A and Malavasi F. 1995. CD38 ligation induces discrete cytokine mRNA expression in human cultured lymphocytes. Eur. J. Immunol. 25: 1477–1480.
Konopleva M, Estrov Z, Zhao S, Andreeff M and Mehta K. 1998. Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells. J. Immunol. 161:4702–4708.
Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, Dianzani U, Stockinger H and Malavasi F. 1998. Human CD38 (ADP ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J. Immunol. 160: 395–402.
Deaglio S, Mehta K and Malavasi F. 2001. Human CD38: a (r)evolutionary story of enzyme and receptor. Leuk. Res. 25: 1–12.
Funaro A, Ferrero E, Mehta K and Malavasi F. 2000. Schematic portrait of CD38 and related molecules. Chem. Immunol. 75: 256–273.
Podesta M, Zocchi E, Pitto A, Usai C, Franco L, Bruzzone S, Guida L, Bacigalupo A, Scadden DT, Walseth TF and De Flora A, Daga A. 2000. Extracellular cyclic ADP-ribose increases intracellular free calcium and stimulates proliferation of human hematopoietic progenitors. FASEB Lett. 14: 680–690.
Okamoto H, Takasawa S, Nata K, Tohgo A and Noguchi N. 2000. Physiological and pathological significance of the CD38-cyclic ADP-ribose signaling system. Chem. Immunol. 75: 122–145.
Antonelli A, Baj G, Marchetti P, Fallahi P, Surico N, Pupilli C, Malavasi F and Ferrannini E. 2001. Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets. Diabetes 50: 985–995.
An NH, Han MK, Urn C, Park BH, Park BJ, Kim HK and Kim UH. 2001. Significance of ecto-cyclase activity of CD38 in insulin secretion of mouse pancreatic islet cells. Biochem. Biophys. Res. Commun. 282: 781–786.
Ibrahim S, Keating M, Do KA, O’Brien S, Huh YO, Jilani I, Lerner S, Kantarjian HM and Albitar M. 2001. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 98: 181–186.
Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Litchman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini, M and Chiorazzi N. 1999. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 91: 1840–1847.
Kramer G, Steiner G, Fodinger D, Fiebiger E, Rappersberger C, Binder S, Hofbauer J and Marberger M. 1995. High expression of a CD38-like molecule in normal prostatic epithelium and its differential loss in benign and malignant disease. J. Urol. 154: 1636–1641.
Bofill M and Borthwick NJ. 2000. CD38 in health and disease. Chem. Immunol. 75: 218–234.
Altucci L and Gronemeyer H. 2001. The promise of retinoids to fight against cancer. Nature Rev. 1: 181–193.
Collinwood TN, Urnov FD and Wolffe AP. 1999. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J. Mol. Edocrinol. 23:255–275.
Chambon P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10: 940–954.
Melnick A and Licht JD. 1999. Deconstructing a disease. RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167–3215.
Boylan JF and Gudas LJ. 1991. Overexpression of the CRABP-1 results in a reduction in differentiation specific gene expression in F9 teratocarcinoma cells. J. Cell Biol. 112:965–979.
Ozpolat B, Lopez-Berestein G and Mehta K. 2001. ATRA(ouble) in the treatment of acute promyelocytic leukemia cells. J. Biol. Regul. Homeost. Agents 15: 107–122.
Glass CK, Rose DW and Rosenfeld MG. 1997. Nucelar receptors coactivators. Curr. Opin. Cell Biol. 9: 222–232.
Collingwood TN, Urnov FD and Wolffe AP. 1999. Nucelar receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J. Mol. Endorinol. 23:255–275.
Malavasi F, Funaro A, Rogerro S, Horenstein A, Calosso L and Mehta K. 1994. CD38: A glycoprotein in search of a function. Immunol. Today 15: 95–97.
Mehta K, McQueen T, Neamati N, Collins S and Andreeff M. 1996. Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Diffren. 7: 179–186.
Drach J, Zhao S, Malavasi F and Mehta K. 1993. Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid. Biochem. Biophys. Res. Commun. 195: 545–550.
Hemmi H and Brietman TR. 1982. Induction by retinoic acid of NAD-glycohydrolase activity of myelomonocytic cell lines HL-60, THP-1 and U937, and fresh human acute promyelocytic leukemia cells in primary culture. Biochem. Biophys. Res. Commun. 109: 669–674.
Kontani K, Nishina H, Ohoka Y, Takahashi K and Katada T. 1993. NAD-glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD-glycohydrolase as leukocyte cell surface antigen CD38. J. Biol. Chem. 268: 16895–16898.
Drach J, McQueen T, Engel H, Andreeff M, Robertson K, Collins SJ, Malavasi F and Mehta K. 1994. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha. Cancer Res. 54: 1746–1752.
Umar S, Malavasi F and Mehta K. 1996. Post-translational modification of CD38 protein into a high molecular weight form alters its catalytic properties. J. Biol. Chem. 271: 15922–15927.
Mehta K, McQueen T, Manshouri T, Andreeff M, Collins S and Albitar M. 1997. Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD38 cell-surface antigen. Blood 89: 3607–3614.
Mehta K and Berestein GL. 1986. Expression of tissue transglutaminase in cultured monocytic leukemia (THP-1) cells during differentiation. Cancer Res. 46:1388–1394.
Davies PJA, Murtaugh MP, Moore WT, Johnson GS and Lucas D. 1985. Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells. J. Biol. Chem. 260: 5166–5174.
Mehta K. 2000. Retinoid-mediated signaling in CD38 antigen expression. Chem. Immunol. 75:20–38.
Kishimoto H, Hoshino S, Ohori M, Kontani K, Nishina H, Suzawa M, Kato S and Katada T. 1997. Molecular mechanism of human CD38 gene expression by retinoic acid. J. Biol. Chem. 273:15429–14434.
Ferrero E, Sccucci F and Malavasi F. 2000. The making of leukocyte receptor: origin, genes and regulation of human CD38 and related molecules. Chem. Immunol. 75:1–19.
Ernst P and Smale ST. 1995. Combinatorila regulation of transcription: general aspects of transcriptional control. Immunity 2: 311–319.
Stoeckler JD, Stoeckler HA, Kouttab N and Maizel AL. 1996. Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes. J. Immunol. 157: 4908–4917.
Musso T, Deaglio S, Franco L, Calosso L, Badolato R, Garbarino G, Dianzani U and Malavasi F. 2001. CD38 expression and functional activities are upregulated by IFN-y on human monocytes and monocytic cell lines. Leuk. Biol. 69: 605–612.
Matsunaga T, Kudo J, Takahashi K, Dohmen K, Hayashida K, Okamura S, Ishibashi H and Niho Y. 1996. Rotenone, a mitochondrial NADH dehydrogenase inhibitor, induces cell surface expression of CD 13 and CD38 and apoptosis in HL-60 cells. Leuk. Lympho. 20: 487–494.
Chini EN, de Toledo FG, Thompson MA and Dousa TP. 1997. Effect of estrogen upon cyclic ADP ribose metabolism: p-estradiol stimulates ADP ribosyl cyclase in rat uterus. Proc. Natl. Acad. Sci. USA 94: 5872–5876.
Abraham E, Carmody A, Shenkar R, Arcaroli J. 2000. Neutrophils as early immunologic factors in hemorrhage-induced acute lung injury. Am. J. Physiol. 279: 1137–1145.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mehta, K. (2002). Retinoid-Mediated Signaling and CD38 Expression. In: Lee, H.C. (eds) Cyclic ADP-Ribose and NAADP. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0269-2_20
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0269-2_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4996-9
Online ISBN: 978-1-4615-0269-2
eBook Packages: Springer Book Archive